{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:56:47Z","timestamp":1787014607197,"version":"build-2736575974"},"reference-count":98,"publisher":"Frontiers Media SA","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2024,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1432-2277.2010.01111.x","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T11:09:08Z","timestamp":1273835348000},"page":"712-722","source":"Crossref","is-referenced-by-count":42,"title":["The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis"],"prefix":"10.3389","volume":"23","author":[{"given":"Sherrie","family":"Bhoori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Germini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgelina","family":"Coppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2010,2,15]]},"reference":[{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF01659064","article-title":"Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients","volume":"15","author":"Ringe","year":"1991","journal-title":"World J Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000658-199109000-00005","article-title":"Hepatic resection versus transplantation for hepatocellular carcinoma","volume":"214","author":"Iwatsuki","year":"1991","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00000658-199308000-00005","article-title":"Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients","volume":"218","author":"Bismuth","year":"1993","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000658-198510000-00001","article-title":"Role of liver transplantation in cancer therapy","volume":"202","author":"Iwatsuki","year":"1985","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB11|cit11","unstructured":"United Network for Organ Sharing http:\/\/www.unos.org\/policiesandbylaws\/policies.asp?resources=true"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1053\/j.gastro.2004.09.040","article-title":"Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy","volume":"127","author":"Wiesner","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(99)00661-3","article-title":"A new splitting technique for liver grafts","volume":"353","author":"Colledan","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1053\/j.gastro.2008.02.092","article-title":"Live donors in liver transplantation","volume":"134","author":"Brown","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2009.04.023","article-title":"Complications of right lobe living donor liver transplantation","volume":"51","author":"Marsh","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00007890-198336060-00010","article-title":"Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity","volume":"36","author":"Iwatsuki","year":"1983","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000658-198911000-00013","article-title":"Orthotopic liver transplantation with preservation of the inferior vena cava","volume":"210","author":"Tzakis","year":"1989","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/13651820410025048","article-title":"Technical progress in liver transplantation","volume":"6","author":"Belghiti","year":"2004","journal-title":"HPB"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1600-6143.2006.01649.x","article-title":"Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis","volume":"7","author":"Selvaggi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.sla.0000189120.62975.0d","article-title":"Technical refinements and results in full-right full-left splitting of the deceased donor liver","volume":"242","author":"Broering","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1072-7515(99)00208-2","article-title":"Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy","volume":"189","author":"Azoulay","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199005243222106","article-title":"Successful liver transplantation from a living donor to her son","volume":"322","author":"Strong","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11938-002-0037-7","article-title":"Adult-to-adult right hepatic lobe living donor liver transplantation","volume":"5","author":"Trotter","year":"2002","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1067\/msy.2001.114218","article-title":"An adult-to-adult living donor liver transplant using dual left lobe grafts","volume":"129","author":"Lee","year":"2001","journal-title":"Surgery"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1111\/j.1432-2277.2010.01067.x","article-title":"Role of oxygen during hypothermic machine perfusion preservation of the liver","author":"Luer","year":"2010","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1600-6143.2009.02731.x","article-title":"Clinical implications of advances in the basic science of liver repair and regeneration","volume":"9","author":"Karp","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/lt.21863","article-title":"Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome","volume":"15","author":"Kelly","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/hep.23437","article-title":"Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma","volume":"15","author":"Toso","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/lt.20808","article-title":"Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language","volume":"12","author":"Majno","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/jlts.2001.25458","article-title":"Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma","volume":"7","author":"Herrero","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/lt.21095","article-title":"Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation","volume":"13","author":"Onaca","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000106911","article-title":"HCC in living donor liver transplantation: can we expand the Milan criteria?","volume":"25","author":"Kwon","year":"2007","journal-title":"Dig Dis"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/lt.21189","article-title":"Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center","volume":"13","author":"Jonas","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000106908","article-title":"Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria","volume":"25","author":"Takada","year":"2007","journal-title":"Dig Dis"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.tp.0000259015.46798.ec","article-title":"Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma","volume":"83","author":"Soejima","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","article-title":"Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series","volume":"25","author":"Sugawara","year":"2007","journal-title":"Dig Dis"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","article-title":"Liver transplantation for hepatocellular carcinoma: Hangzhou experiences","volume":"85","author":"Zheng","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","article-title":"Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center","volume":"14","author":"Lee","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.21576","article-title":"Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma","volume":"14","author":"Silva","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.21484","article-title":"Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma","volume":"14","author":"Toso","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.20995","article-title":"Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation","volume":"13","author":"Terrault","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1053\/j.gastro.2004.09.042","article-title":"Living donor liver transplantation for hepatocellular carcinoma","volume":"127","author":"Kulik","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.22693","article-title":"Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database","volume":"49","author":"Toso","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1432-2277.2009.00882.x","article-title":"The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria","volume":"22","author":"Toso","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11605-006-0033-7","article-title":"Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants","volume":"11","author":"Shah","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","article-title":"Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies","volume":"7","author":"Edmonson","year":"1954","journal-title":"Cancer"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cncr.20798","article-title":"Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma","volume":"103","author":"Sasaki","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1091-255X(01)00015-4","article-title":"Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation","volume":"6","author":"Esnaola","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1432-2277.2007.00505.x","article-title":"Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience","volume":"20","author":"Zimmerman","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.sla.0000109146.72827.76","article-title":"Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma","volume":"239","author":"Cillo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.sla.0000250420.73854.ad","article-title":"Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility","volume":"245","author":"Pawlik","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1600-6143.2006.01321.x","article-title":"Waiting list removal rates among patients with chronic and malignant liver diseases","volume":"6","author":"Freeman","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1600-6143.2006.01572.x","article-title":"Waiting list treatment of hepatocellular carcinoma: when do we need level 1 evidence?","volume":"6","author":"Schwartz","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/jlts.2002.34923","article-title":"Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/jlts.2002.31749","article-title":"Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma","volume":"8","author":"Cheng","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.50.1.123","article-title":"Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation","volume":"50","author":"Llovet","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/jlts.2003.50147","article-title":"A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy","volume":"9","author":"Yao","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.20688","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation","volume":"41","author":"Lu","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.2214\/AJR.04.1927","article-title":"Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison","volume":"186","author":"Brillet","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","article-title":"Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study","volume":"240","author":"Mazzaferro","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/jlts.2002.36394","article-title":"Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation","volume":"8","author":"Fontana","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"Llovet","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2006.01509.x","article-title":"Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis","volume":"6","author":"Lesurtel","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lt.21033","article-title":"Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma","volume":"13","author":"Millonig","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/01.TP.0000145892.97114.EE","article-title":"Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation","volume":"78","author":"Ravaioli","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0b013e31818eec29","article-title":"The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review","volume":"249","author":"Lau","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jamcollsurg.2006.06.016","article-title":"Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival","volume":"203","author":"Bharat","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-6143.2005.00750.x","article-title":"The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma","volume":"5","author":"Yao","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma","volume":"127","author":"Geschwind","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.23260","article-title":"Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety","volume":"51","author":"Vitale","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","article-title":"Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis","volume":"48","author":"Yao","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","article-title":"Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria","volume":"8","author":"Ravaioli","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1600-6143.2006.01719.x","article-title":"Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria","volume":"7","author":"Cillo","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","article-title":"Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA","volume":"246","author":"Duffy","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","article-title":"Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation","volume":"248","author":"Chapman","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000658-199712000-00006","article-title":"Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis","volume":"226","author":"Majno","year":"1997","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lt.20418","article-title":"Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma","volume":"11","author":"Decaens","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000658-200204000-00012","article-title":"Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters","volume":"235","author":"Roayaie","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/jlts.2003.50106","article-title":"Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome","volume":"9","author":"Graziadei","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.surg.2006.11.006","article-title":"A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma","volume":"141","author":"Yang","year":"2007","journal-title":"Surgery"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1600-6143.2009.02746.x","article-title":"Is downstaging prior to liver transplantation important in hepatocellular carcinoma?","volume":"9","author":"Lee","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.sla.0000090449.87109.44","article-title":"Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?","volume":"238","author":"Adam","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.transproceed.2007.06.015","article-title":"First-line treatment for hepatocellular carcinoma: resection or transplantation?","volume":"39","author":"Bhoori","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/lt.20202","article-title":"High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation","volume":"10","author":"Sala","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/lt.20398","article-title":"Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation","volume":"11","author":"Margarit","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/SLA.0b013e3181bd582b","article-title":"Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation","volume":"250","author":"Cherqui","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/he.2000.5763","article-title":"Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis","volume":"31","author":"Majno","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00148365-200504040-00007","article-title":"Determining priority for liver transplantation: a comparison of cost per QALY and discrete choice experiment-generated public preferences","volume":"4","author":"Ratcliffe","year":"2005","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1111\/j.1432-2277.2010.01111.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/lt.21648","article-title":"The validity of EQ-5D US preference weights in liver transplant candidates and recipients","volume":"15","author":"Russell","year":"2009","journal-title":"Liver Transpl"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2010.01111.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2010.01111.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T13:38:58Z","timestamp":1641044338000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2010.01111.x"}},"subtitle":["Liver transplantation for HCC"],"short-title":[],"issued":{"date-parts":[[2010,2,15]]},"references-count":98,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2010.01111.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,15]]}}}